| Acronym | Definition | Acronym | Definition |
| APC | Antigen-presenting cell | NY-ESO-1 | New York esophageal squamous cell carcinoma 1 |
| ATMP | Advanced-therapy medicinal product | PD-1 | Programmed cell death protein 1 |
| CAR-T | Chimeric antigen receptor–T cell | PD-L1 | Programmed death ligand 1 |
| CSC | Cancer stem cell | scFv | Single-chain variable fragment |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 | TAM | Tumor-associated macrophage |
| CTLs | Cytotoxic T lymphocytes | TCR | T cell receptor |
| ECM | Extracellular matrix | TFH | T follicular helper |
| EGF | Epidermal growth factor | TGF | Transforming growth factor |
| EGFR | Epidermal growth factor receptor | TIGIT | T-cell immunoreceptor and ITIM domains |
| HER2 | Human epidermal growth factor receptor 2 | TIL | Tumor-infiltrating lymphocyte |
| ICI | Immune checkpoint inhibitor | Tim-3 | T cell immunoglobulin and mucin domain 3 |
| IDO | Indolamine-2,3-dioxygenase | TMB | Tumor mutational burden |
| LAG-3 | Lymphocyte activation gene-3 | TME | Tumor microenvironment |
| MDSC | Myeloid-derived suppressor cell | TNF | Tumor necrosis factor |
| MMP | Matrix metalloprotease | Treg | Regulatory T cell |
| MYCN | N-myc proto-oncogene | VEGF | Vascular endothelial growth factor |